WAS
CVS icon

WESPAC Advisors SoCal’s CVS Health CVS Stock Holding History

WESPAC Advisors SoCal’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-51,255
Closed -$3.81M – 86
2023
Q1 		$3.81M Buy
51,255
+337
+0.7% +$28.3K 1.31% 29
2022
Q4 		$4.75M Buy
50,918
+393
+0.8% +$37.9K 1.76% 22
2022
Q3 		$4.79M Buy
50,525
+40,570
+408% +$4.02M 2% 21
2022
Q2 		$922K Buy
+9,955
New +$972K 0.35% 43
2019
Q2 		– Sell
-100
Closed -$5K – 130
2019
Q1 		$5K Hold
100
– – ﹤0.01% 283
2018
Q4 		$6K Hold
100
– – ﹤0.01% 274
2018
Q3 		$7K Buy
+100
New +$7.15K ﹤0.01% 254
2018
Q2 		– Sell
-150
Closed -$9K – 122
2018
Q1 		$9K Hold
150
– – 0.01% 197
2017
Q4 		$10K Sell
150
-60,831
-100% -$4.42M 0.01% 188
2017
Q3 		$4.96M Sell
60,981
-1,989
-3% -$157K 2.95% 13
2017
Q2 		$5.07M Buy
62,970
+291
+0.5% +$23K 3.24% 9
2017
Q1 		$4.92M Buy
62,679
+8,075
+15% +$645K 3.05% 13
2016
Q4 		$4.31M Sell
54,604
-8,484
-13% -$686K 2.79% 15
2016
Q3 		$5.61M Sell
63,088
-684
-1% -$64.6K 3.79% 3
2016
Q2 		$6.11M Buy
63,772
+24,865
+64% +$2.48M 3.97% 2
2016
Q1 		$4.04M Buy
38,907
+675
+2% +$65.6K 2.97% 12
2015
Q4 		$3.74M Buy
+38,232
New +$3.74M 2.47% 18

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

WESPAC Advisors SoCal's CVS Position: Q2 2023 in Review

WESPAC Advisors SoCal sold out of CVS Health (CVS) in Q2 2023, closing a stake of 51,255 shares — an estimated $3.81M sold.

WESPAC Advisors SoCal first reported a position in CVS in Q4 2015 and held it in 17 quarters. The position peaked at $6.11M in Q2 2016. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • WESPAC Advisors SoCal reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 51,255 CVS Health shares in Q2 2023, an estimated $3.81M.
  • WESPAC Advisors SoCal first reported a position in CVS Health in Q4 2015 and held it in 17 quarters.
  • WESPAC Advisors SoCal's CVS Health position peaked at $6.11M in Q2 2016.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2023, filed 20 Jul 2023.